Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Garber

Showing results (451-460 of 605) with videos related to

Pageof 61
Sort By:
Breast Cancer Research and Treatment|April 23, 2010
Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomyLori J Pierce, Kelly-Anne Phillips, Kent A Griffith, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 28, 2003
Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated)Steven M Opal, Gary E Garber, Steven P LaRosa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2017
Discrimination of Germline <i>EGFR</i> T790M Mutations in Plasma Cell-Free DNA Allows Study of Prevalence Across 31,414 Cancer PatientsYuebi Hu, Ryan S Alden, Justin I Odegaard, et al.
International Journal of Radiation Oncology, Biology, Physics|October 26, 2005
Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancerHarold J Burstein, Jennifer R Bellon, Sharon Galper, et al.
Cancer Research|July 17, 2001
Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive historyT R Rebbeck, Y Wang, P W Kantoff, et al.
Journal of Genetic Counseling|November 16, 2006
Ethical issues in cancer genetics: I 1) whose information is it?Katherine A Schneider, Anu B Chittenden, Kelly J Branda, et al.
Breast Cancer Research : BCR|February 13, 2010
Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic featuresNadine Tung, Yihong Wang, Laura C Collins, et al.
Medrxiv : the Preprint Server for Health Sciences|September 15, 2025
Clonal Hematopoiesis Dynamics and Evolutionary Fitness During Cancer Treatment Impact Clinical OutcomesMona Arabzadeh, Yi-Han Tang, Christelle Colin-Leitzinger, et al.
Cancer Discovery|June 17, 2018
Precision Prevention and Early Detection of Cancer: Fundamental PrinciplesTimothy R Rebbeck, Karen Burns-White, Andrew T Chan, et al.
The Journal of Clinical Investigation|June 9, 2026
Evolution of clonal hematopoiesis during cancer treatment and its impact on outcomesMona Arabzadeh, Yi-Han Tang, Christelle Colin-Leitzinger, et al.
Pageof 61

Showing results (451-460 of 605) with videos related to

Sort By:
Pageof 61
Breast Cancer Research and Treatment|April 23, 2010
Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomyLori J Pierce, Kelly-Anne Phillips, Kent A Griffith, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 28, 2003
Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated)Steven M Opal, Gary E Garber, Steven P LaRosa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2017
Discrimination of Germline <i>EGFR</i> T790M Mutations in Plasma Cell-Free DNA Allows Study of Prevalence Across 31,414 Cancer PatientsYuebi Hu, Ryan S Alden, Justin I Odegaard, et al.
International Journal of Radiation Oncology, Biology, Physics|October 26, 2005
Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancerHarold J Burstein, Jennifer R Bellon, Sharon Galper, et al.
Cancer Research|July 17, 2001
Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive historyT R Rebbeck, Y Wang, P W Kantoff, et al.
Journal of Genetic Counseling|November 16, 2006
Ethical issues in cancer genetics: I 1) whose information is it?Katherine A Schneider, Anu B Chittenden, Kelly J Branda, et al.
Breast Cancer Research : BCR|February 13, 2010
Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic featuresNadine Tung, Yihong Wang, Laura C Collins, et al.
Medrxiv : the Preprint Server for Health Sciences|September 15, 2025
Clonal Hematopoiesis Dynamics and Evolutionary Fitness During Cancer Treatment Impact Clinical OutcomesMona Arabzadeh, Yi-Han Tang, Christelle Colin-Leitzinger, et al.
Cancer Discovery|June 17, 2018
Precision Prevention and Early Detection of Cancer: Fundamental PrinciplesTimothy R Rebbeck, Karen Burns-White, Andrew T Chan, et al.
The Journal of Clinical Investigation|June 9, 2026
Evolution of clonal hematopoiesis during cancer treatment and its impact on outcomesMona Arabzadeh, Yi-Han Tang, Christelle Colin-Leitzinger, et al.
Pageof 61